1 / 4

Global Monoclonal Antibodies Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2020-2026

The global monoclonal antibodies market is estimated to grow at a CAGR of 8.6% during the forecast period. An increasing number of trials for monoclonal antibodies for COVID-19 patients.

nabeelomr
Download Presentation

Global Monoclonal Antibodies Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global monoclonal antibodies market is estimated to grow at a CAGR of 8.6% during the forecast period. An increasing number of trials for monoclonal antibodies for COVID-19 patients. For instance, in October 2020, Celltrion Group declared the introduction of its Phase III clinical trial investigating CT-P59. It is an anti-COVID-19 monoclonal antibody therapy candidate. The company estimates the enrolment of nearly 1,000 patients to assess population- based prophylaxis in contacts of SARS-CoV-2 infected patients. The prophylaxis post-exposure clinical trial will assess the safety and preventive effect of CT-P59 and whether CT-P59 can produce a counteracting antibody response for the prevention of virus from infecting human cells. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/monoclonal- antibodies-market Further, in August 2020, the National Institutes of Health (NIH) introduced a clinical trial that aims to test antibody therapy in hospitalized COVID-19 patients. Under the trial, COVID-19 patients at selected hospitals can volunteer in a clinical trial intended to test the efficacy and safety of an effective novel treatment for COVID-19. It is a Phase 3 randomized, controlled trial which is referred to as ACTIV-3, and as a master protocol. This is designed to test several diverse kinds of monoclonal antibody therapies. One of the major benefits of monoclonal antibody therapy is that it can particularly target the SARS-CoV-2 virus and this makes them more potential compared to other drugs. Browse for Full Report at: https://www.omrglobal.com/industry-reports/monoclonal- antibodies-market Scope of the Global Monoclonal Antibodies Market Market Coverage •Market number available for 2019-2026 •Base year- 2019

  2. •Forecast period- 2020-2026 •Segment Covered- By Source and Application •Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World •Competitive Landscape- Amgen Inc., Eli Lilly & Co., F- Hoffman La-Roche AG, Pfizer Inc., and Novartis AG Recent Strategic Initiatives in the Global Monoclonal Antibodies Market •In December 2019, Mylan N.V. and Biocon Ltd. declared the US FDA launch of Ogivri (trastuzumab-dkst). It is biosimilar to Herceptin (trastuzumab). It was the first biosimilar trastuzumab approved by the US FDA for all indications which includes treatment of HER2-overexpressing metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) and breast cancer. •In June 2018, Pfizer Inc. announced the approval of ZIRABEV (bevacizumab-bvzr) in the US. It is a biosimilar to Avastin (bevacizumab) which is indicated to treat five kinds of cancer, including locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC), metastatic colorectal cancer, unresectable, metastatic renal cell carcinoma (RCC), recurrent glioblastoma; and persistent, recurrent or metastatic cervical cancer. Global Monoclonal Antibodies Market-Segmentation By Source •Murine •Chimeric •Human •Humanized By Application •Cancer

  3. •Infectious Diseases •Auto-Immune Diseases •Inflammatory Diseases •Others Global Monoclonal Antibodies Market– Segment by Region North America •United States •Canada Europe •UK •Germany •Italy •Spain •France •Rest of Europe Asia-Pacific •China •India •Japan •Rest of Asia-Pacific Rest of the World •Middle East & Africa •Latin America

  4. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/monoclonal-antibodies-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related